The thyroid hormone receptor and the insulator protein CTCF: Two different factors with overlapping functions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 83, Issue 1-5, 2002, Pages 49-57

  Burke, L J ^a   Zhang, R ^a   Lutz, M ^a   Renkawitz, R ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Chromatin remodelling; CTCF; DNA bending; Histone deacetylase; Thyroid hormone receptor; Transcriptional synergy

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GENE PRODUCT; LIOTHYRONINE; LYSOZYME; MYC PROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROXINE; ZINC FINGER PROTEIN; CCCTC BINDING FACTOR; CCCTC-BINDING FACTOR; DNA BINDING PROTEIN; LIGAND; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

CONFERENCE PAPER; GENE EXPRESSION REGULATION; HUMAN; LIPOGENESIS; LIPOLYSIS; MOLECULAR BIOLOGY; NONHUMAN; OXIDATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ZINC FINGER MOTIF; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CHROMATIN; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

ANIMALS; BINDING SITES; CHROMATIN; DNA-BINDING PROTEINS; HUMANS; LIGANDS; MODELS, BIOLOGICAL; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROID HORMONE; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 0037981378     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00256-X     Document Type: Conference Paper

References (78)

1. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:2001;1097-1142.
2. Beck-Peccoz P., Chatterjee V.K. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid. 4:1994;225-232.
3. Refetoff S. Resistance to thyroid hormone and its molecular basis. Acta Paediatr. Jpn. 36:1994;1-15.
4. Refetoff S. Resistance to thyroid hormone. Curr. Ther. Endocrinol. Metab. 5:1994;117-119.
5. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:1994;391-407.
6. Rosenfeld M.G., Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276:2001;36865-36868.
7. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
8. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., Tenbaum S.P., Renkawitz R., Baniahmad A. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol. 19:1999;3383-3394.
9. Hörlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
10. Zamir I., Dawson J., Lavinsky R.M., Glass C.K., Rosenfeld M.G., Lazar M.A. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14400-14405.
11. Lin H.M., Zhao L., Cheng S.Y. Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J. Biol. Chem. 277:2002;28733-28741.
12. Alland L., Muhle R., Hou H. III, Potes J., Chin L., Schreiber-Agus N., DePinho R.A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature. 387:1997;49-55.
13. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 89:1997;341-347.
14. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., Yang W.M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K., Rosenfeld M.G. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature. 387:1997;43-48.
15. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell. 89:1997;349-356.
16. Nagy L., Kao H.Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L., Evans R.M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell. 89:1997;373-380.
17. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 89:1997;357-364.
18. Huang E.Y., Zhang J., Miska E.A., Guenther M.G., Kouzarides T., Lazar M.A. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev. 14:2000;45-54.
19. Kao H.Y., Downes M., Ordentlich P., Evans R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:2000;55-66.
20. Downes M., Ordentlich P., Kao H.Y., Alvarez J.G., Evans R.M. Identification of a nuclear domain with deacetylase activity. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10330-10335.
21. Shi Y., Downes M., Xie W., Kao H.Y., Ordentlich P., Tsai C.C., Hon M., Evans R.M. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes. Dev. 15:2001;1140-1151.
22. Underhill C., Qutob M.S., Yee S.P., Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J. Biol. Chem. 275:2000;40463-40470.
23. Li J., Lin Q., Yoon H.G., Huang Z.Q., Strahl B.D., Allis C.D., Wong J. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol. Cell Biol. 22:2002;5688-5697.
24. Baniahmad A., Ha I., Reinberg D., Tsai S., Tsai M.J., O'Malley B.W. Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8832-8836.
25. Fondell J.D., Roy A.L., Roeder R.G. Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes. Dev. 7:1993;1400-1410.
26. Muscat G.E., Burke L.J., Downes M. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70. Nucl. Acids Res. 26:1998;2899-2907.
27. Wong C.W., Privalsky M.L. Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol. Cell Biol. 18:1998;5500-5510.
28. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:1999;321-344.
29. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes. Dev. 14:2000;121-141.
30. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M., Evans R.M. A transcriptional switch mediated by cofactor methylation. Science. 294:2001;2507-2511.
31. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science. 284:1999;2174-2177.
32. Koh S.S., Chen D., Lee Y.H., Stallcup M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 276:2001;1089-1098.
33. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., Henschen-Edman A., Mackay D.R., Stallcup M.R., Aswad D.W. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry. 40:2001;5747-5756.
34. Fondell J.D., Guermah M., Malik S., Roeder R.G. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1959-1964.
35. Rachez C., Suldan Z., Ward J., Chang C.P., Burakov D., Erdjument-Bromage H., Tempst P., Freedman L.P. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes. Dev. 12:1998;1787-1800.
36. Sasaki S., Lesoon-Wood L.A., Dey A., Kuwata T., Weintraub B.D., Humphrey G., Yang W.M., Seto E., Yen P.M., Howard B.H., Ozato K. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. Embo J. 18:1999;5389-5398.
37. Belandia B., Latasa M.J., Villa A., Pascual A. Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene. J. Biol. Chem. 273:1998;30366-30371.
38. Bigler J., Eisenman R.N. Novel location and function of a thyroid hormone response element. Embo J. 14:1995;5710-5723.
39. Perez-Juste G., Garcia-Silva S., Aranda A. An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J. Biol. Chem. 275:2000;1307-1314.
40. Saatcioglu F., Deng T., Karin M. A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation. Cell. 75:1993;1095-1105.
41. Zhang W., Brooks R.L., Silversides D.W., West B.L., Leidig F., Baxter J.D., Eberhardt N.L. Negative thyroid hormone control of human growth hormone gene expression is mediated by 3′-untranslated/3′-flanking DNA. J. Biol. Chem. 267:1992;15056-15063.
42. Lobanenkov V.V., Nicolas R.H., Adler V.V., Paterson H., Klenova E.M., Polotskaja A.V., Goodwin G.H. A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5′-flanking sequence of the chicken c-myc gene. Oncogene. 5:1990;1743-1753.
43. Baniahmad A., Steiner C., Kohne A.C., Renkawitz R. Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell. 61:1990;505-514.
44. Klenova E.M., Nicolas R.H., Paterson H.F., Carne A.F., Heath C.M., Goodwin G.H., Neiman P.E., Lobanenkov V.V. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol. Cell Biol. 13:1993;7612-7624.
45. Filippova G.N., Fagerlie S., Klenova E.M., Myers C., Dehner Y., Goodwin G., Neiman P.E., Collins S.J., Lobanenkov V.V. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc-fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell Biol. 16:1996;2802-2813.
46. Burcin M., Arnold R., Lutz M., Kaiser B., Runge D., Lottspeich F., Filippova G.N., Lobanenkov V.V., Renkawitz R. Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc-finger repressor CTCF. Mol. Cell Biol. 17:1997;1281-1288.
47. Burke L.J., Hollemann T., Pieler T., Renkawitz R. Molecular cloning and expression of the chromatin insulator protein CTCF in Xenopus laevis. Mech. Dev. 113:2002;95-98.
48. Rasko J.E., Klenova E.M., Leon J., Filippova G.N., Loukinov D.I., Vatolin S., Robinson A.F., Hu Y.J., Ulmer J., Ward M.D., Pugacheva E.M., Neiman P.E., Morse H.C. III, Collins S.J., Lobanenkov V.V. Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF. Cancer Res. 61:2001;6002-6007.
49. Filippova G.N., Qi C.F., Ulmer J.E., Moore J.M., Ward M.D., Hu Y.J., Loukinov D.I., Pugacheva E.M., Klenova E.M., Grundy P.E., Feinberg A.P., Cleton-Jansen A.M., Moerland E.W., Cornelisse C.J., Suzuki H., Komiya A., Lindblom A., Dorion-Bonnet F., Neiman P.E., Morse H.C. III, Collins S.J., Lobanenkov V.V. Tumor-associated zinc-finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. Cancer Res. 62:2002;48-52.
50. Filippova G.N., Lindblom A., Meincke L.J., Klenova E.M., Neiman P.E., Collins S.J., Doggett N.A., Lobanenkov V.V. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF. Genes Chromosomes Cancer. 22:1998;26-36.
51. Vostrov A.A., Quitschke W.W. The zinc-finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. J. Biol. Chem. 272:1997;33353-33359.
52. Ohlsson R., Renkawitz R., Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 17:2001;520-527.
53. West A.G., Gaszner M., Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev. 16:2002;271-288.
54. Bell A.C., West A.G., Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell. 98:1999;387-396.
55. Farrell C.M., West A.G., Felsenfeld G. Conserved CTCF insulator elements flank the mouse and human beta-globin loci. Mol. Cell Biol. 22:2002;3820-3831.
56. Bell A.C., Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature. 405:2000;482-485.
57. Hark A.T., Schoenherr C.J., Katz D.J., Ingram R.S., Levorse J.M., Tilghman S.M. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 405:2000;486-489.
58. Kanduri C., Pant V., Loukinov D., Pugacheva E., Qi C.F., Wolffe A., Ohlsson R., Lobanenkov V.V. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr. Biol. 10:2000;853-856.
59. Kanduri M., Kanduri C., Mariano P., Vostrov A.A., Quitschke W., Lobanenkov V., Ohlsson R. Multiple nucleosome positioning sites regulate the CTCF-mediated insulator function of the H19 imprinting control region. Mol. Cell Biol. 22:2002;3339-3344.
60. Nakagawa H., Chadwick R.B., Peltomaki P., Plass C., Nakamura Y., de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 98:2001;591-596.
61. Cui H., Niemitz E.L., Ravenel J.D., Onyango P., Brandenburg S.A., Lobanenkov V.V., Feinberg A.P. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res. 61:2001;4947-4950.
62. Takai D., Gonzales F.A., Tsai Y.C., Thayer M.J., Jones P.A. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum. Mol. Genet. 10:2001;2619-2626.
63. Filippova G.N., Thienes C.P., Penn B.H., Cho D.H., Hu Y.J., Moore J.M., Klesert T.R., Lobanenkov V.V., Tapscott S.J. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 28:2001;335-343.
64. Chao W., Huynh K.D., Spencer R.J., Davidow L.S., Lee J.T. CTCF, a candidate trans-acting factor for X-inactivation choice. Science. 295:2002;345-347.
65. Lutz M., Burke L.J., Barreto G., Goeman F., Greb H., Arnold R., Schultheiss H., Brehm A., Kouzarides T., Lobanenkov V., Renkawitz R. Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucl. Acids Res. 28:2000;1707-1713.
66. Klenova E.M., Chernukhin I.V., El-Kady A., Lee R.E., Pugacheva E.M., Loukinov D.I., Goodwin G.H., Delgado D., Filippova G.N., Leon J., Morse H.C. III, Neiman P.E., Lobanenkov V.V. Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF. Mol. Cell Biol. 21:2001;2221-2234.
67. Chernukhin I.V., Shamsuddin S., Robinson A.F., Carne A.F., Paul A., El-Kady A.I., Lobanenkov V.V., Klenova E.M. Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc-finger factor, CTCF. J. Biol. Chem. 275:2000;29915-29921.
68. Köhne A.C., Baniahmad A., Renkawitz R. NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing. J. Mol. Biol. 232:1993;747-755.
69. Awad T.A., Bigler J., Ulmer J.E., Hu Y.J., Moore J.M., Lutz M., Neiman P.E., Collins S.J., Renkawitz R., Lobanenkov V.V., Filippova G.N. Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J. Biol. Chem. 274:1999;27092-27098.
70. Quitschke W.W. Two nuclear factor binding domains activate expression from the human amyloid beta-protein precursor promoter. J. Biol. Chem. 269:1994;21229-21233.
71. Quitschke W.W., Matthews J.P., Kraus R.J., Vostrov A.A. The initiator element and proximal upstream sequences affect transcriptional activity and start site selection in the amyloid beta-protein precursor promoter. J. Biol. Chem. 271:1996;22231-22239.
72. Steiner C., Muller M., Baniahmad A., Renkawitz R. Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. Nucl. Acids Res. 15:1987;4163-4178.
73. Lutz M., Baniahmad A., Renkawitz R. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor. Biochem. Soc. Trans. 28:2000;386-389.
74. Arnold R., Burcin M., Kaiser B., Muller M., Renkawitz R. DNA bending by the silencer protein NeP1 is modulated by TR and RXR. Nucl. Acids Res. 24:1996;2640-2647.
75. Lee S., Hahn S. Model for binding of transcription factor TFIIB to the TBP-DNA complex. Nature. 376:1995;609-612.
76. Sharrocks A.D., Shore P. DNA bending in the ternary nucleoprotein complex at the c-fos promoter. Nucl. Acids Res. 23:1995;2442-2449.
77. Shulemovich K., Dimaculangan D.D., Katz D., Lazar M.A. DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR. Nucl. Acids Res. 23:1995;811-818.
78. Mackay J.P., Crossley M. Zinc-fingers are sticking together. Trends Biochem. Sci. 23:1998;1-4.